Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy
Part of paid clinical trials in New Brunswick, New Jersey.
- Sponsor
- Rutgers, The State University of New Jersey
- Study ID
- NCT06814184
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Not accepted
Interventions
- app-based nurse-led virtual diabetes care — BEHAVIORALA nurse-led, app-based behavioral intervention consisting of (1) education via MyChart messaging, (2) problem solving with an action plan via phone, and (3) remote patient monitoring via mySugr app to identify the need to adjust treatment
Study Details
This 12-month pilot tests a nurse-led, app-based intervention to improve diabetes self-management for Medicaid patients. It includes MyChart messaging to give education, phone help on problem-solving with clinicians, and using a diabetes app to track data. The study aims to enhance self-management behaviors through health technology.
Key Dates
- Start date
- Apr 1, 2026
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Experimental with interventionIntervention starts at enrollment
- Other: Delayed InterventionIntervention delivery 3 months after enrollment
Primary Outcome Measure
Glycemic control: glycated hemoglobin AIC [ Time Frame: baseline, 3, 6, 9, and 12 months ]
Central Contacts
- Helen NC Chen, PhD(908) 466-3953
- Toya Williams, MPH(732) 235-7380
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rutgers Health Family Medicine at Monument Square | New Brunswick | New Jersey | 08901 | |
| University Medical Group General Internal Medicine | New Brunswick | New Jersey | 08901 |
Find similar trials in New Brunswick, NJ
By condition
By specialty
Related Studies
- Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II DiabetesRecruiting · Endogenex, Inc. · Birmingham, Alabama
- Extracellular Vesicles, Insulin Action, and ExerciseRecruiting · Rutgers, The State University of New Jersey · New Brunswick, New Jersey
- Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic PatientsRecruiting · Rutgers, The State University of New Jersey · New Brunswick, New Jersey
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatidePHASE2 · Recruiting · Eli Lilly and Company · Phoenix, Arizona